Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

ThredUp Reports Strong Revenue Growth in Q4 2023 and Optimistic Outlook for 2024

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
DrugRetailers Stock Market Today
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

ThredUp, a leading fashion resale platform, announced its quarterly financial results on March 4, 2024. The company reported a loss of $(0.140) per share, which was below analysts’ expectations by 16.67%. However, ThredUp exceeded revenue projections with quarterly sales reaching $81.393 million, a 1.32% increase from the forecasted $80.329 million. This marks a significant 14.13% growth compared to the same period last year.

In the fourth quarter of 2023, ThredUp generated $81.4 million in revenue, demonstrating a strong 14% year-over-year improvement. Looking ahead, the company is optimistic about its financial performance in 2024, forecasting revenue in the range of $340 million to $350 million. ThredUp also aims to achieve an Adjusted EBITDA margin between 0.5% and 1.5%, indicating a positive outlook for the year ahead.

TDUP Stock Shows Promising Price Momentum on March 4, 2024: Analysis and Insights

On March 4, 2024, TDUP stock showed some promising signs of price momentum. The stock closed at $2.36, which was a significant increase of $0.25 or 11.85% from the previous market close. This positive movement was certainly welcomed by investors who have been closely monitoring the stock’s performance.

However, despite this initial surge, TDUP is still trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that while there may have been some short-term gains, the stock may still be facing some resistance in reaching higher price levels.

Furthermore, in after-hours trading, TDUP experienced a slight drop of $0.18. While this may be a cause for concern for some investors, it is important to remember that after-hours trading can often be more volatile and may not always reflect the true value of a stock.

Overall, the performance of TDUP on March 4, 2024, showed some positive price momentum with a notable increase in share price. However, investors should continue to monitor the stock closely and consider the broader market trends before making any investment decisions.

TDUP Stock Performance Analysis: Revenue Up, Net Income Down – March 4, 2024

On March 4, 2024, TDUP stock had a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $288.38 million, showing a 14.53% increase compared to the previous year. However, in the third quarter, the total revenue dropped to $82.05 million, holding flat since the last quarter.

The net income for TDUP was -$92.28 million for the past year, indicating a 46.07% decrease from the previous year. In the third quarter, the net income improved slightly to -$18.08 million, showing a 3.61% increase since the last quarter.

Earnings per share (EPS) for TDUP were -$0.92 for the past year, reflecting a 44.05% decrease from the previous year. In the third quarter, the EPS improved to -$0.17, representing a 5.37% increase since the last quarter.

Overall, TDUP stock had a challenging year with a significant drop in net income and earnings per share. However, there were signs of improvement in the third quarter, with a slight increase in net income and EPS compared to the previous quarter.

Tags: TDUP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Doctor on mobile phone

Health Tech Innovations: Transforming Healthcare Delivery and Monitoring

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Automotive Stock Market Today

NIO Inc Announces Strong Vehicle Sales in Fourth Quarter of 2023

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com